Unique ID issued by UMIN | UMIN000044428 |
---|---|
Receipt number | R000050525 |
Scientific Title | Clinical Trial Mock Simulation Research Plan Phase IIb Trial in Fistulising Crohn's Disease |
Date of disclosure of the study information | 2021/06/04 |
Last modified on | 2022/03/01 17:45:28 |
Clinical Trial Mock Simulation Research Plan
Phase IIb Trial in Fistulising Crohn's Disease
Clinical Trial Mock Simulation Research Plan
Phase IIb Trial in Fistulising Crohn's Disease
Clinical Trial Mock Simulation Research Plan
Phase IIb Trial in Fistulising Crohn's Disease
Clinical Trial Mock Simulation Research Plan
Phase IIb Trial in Fistulising Crohn's Disease
Japan | Asia(except Japan) | Europe |
Fistulising Crohn's Disease
Gastroenterology |
Others
NO
The objective of this clinical trial mock simulation is to gather patient and healthcare provider
(HCP) feedback about the design of a Phase IIb trial in fistulising CD in order to:
Understand patient and caregiver needs and expectations
Deliver on patient and caregiver needs in BI trial and non-trial activities
Raise patient satisfaction with BI trials, medicines and support services
Enhance disease awareness and patient information
Support patient access to care and healthcare services
Understand and support the objectives of patient organisations
Others
Not applicable
Experience with conducting clinical trials, e.g. investigator or study coordinator
Observational
18 | years-old | <= |
Not applicable |
Male and Female
PATIENTS
Diagnosis of fistulising CD
Male or female patients
18+ years old
HEALTH CAREPROFESSIONAL
Experience with conducting clinical trials, e.g. investigator or study coordinator
From the same country as the patient with whom they will participate in the virtual
trial visit simulation
None
12
1st name | Nobutaka |
Middle name | |
Last name | Yagi |
Nippon Boehringer Ingelheim Co., Ltd.
Medicine Division
141-6017
2-1-1 Osaki, Shinagawa-ku, Tokyo, Japan
03-6417-2043
nobutaka.yagi@boehringer-ingelheim.com
1st name | Nobutaka |
Middle name | |
Last name | Yagi |
Nippon Boehringer Ingelheim Co., Ltd.
Medicine Division
141-6017
2-1-1 Osaki, Shinagawa-ku, Tokyo, Japan
03-6417-2043
nobutaka.yagi@boehringer-ingelheim.com
Nippon Boehringer Ingelheim Co., Ltd.
Nippon Boehringer Ingelheim Co., Ltd.
Profit organization
Medical Corporation Kyoso-kai AMC Nishi-Umeda Clinic Ethics Review Committee
Maruit Nishi-Umeda Building 3F, 3-3-45 Umeda, Kita-ku, Osaka-shi, Osaka, Japan
06-4797-5660
morikawa@amc-clinic.jp
NO
2021 | Year | 06 | Month | 04 | Day |
Unpublished
3
Completed
2020 | Year | 12 | Month | 09 | Day |
2021 | Year | 05 | Month | 21 | Day |
2021 | Year | 05 | Month | 24 | Day |
2021 | Year | 11 | Month | 18 | Day |
Non-interventional study
2021 | Year | 06 | Month | 04 | Day |
2022 | Year | 03 | Month | 01 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050525
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |